Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Jul 07, 2020	Landry Robert E EVP Finance CFO Trans History: 465	EVP Finance CFO	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	10,000	$555.67	33,973
Jun 22, 2020	Landry Robert E EVP Finance CFO Trans History: 465	EVP Finance CFO	Form 4	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3	8,900	$555.67	33,273
Sep 21, 2020	GOLDSTEIN JOSEPH L Director Trans History: 381	Director	Form 4	Open market or private sale of non-derivative or derivative security	1,530	$555.74	5,663
May 06, 2020	BROWN MICHAEL S Director Trans History: 466	Director	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	3,538	$555.77	2,325
May 06, 2020	BROWN MICHAEL S Director Trans History: 466	Director	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	123	$555.77	2,452
May 06, 2020	Van Plew Daniel P EVP & General Mgr Industrial O Trans History: 359	EVP & General Mgr Industrial O	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	17,779	$555.77	43,551
May 06, 2020	Van Plew Daniel P EVP & General Mgr Industrial O Trans History: 359	EVP & General Mgr Industrial O	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	28,217	$555.77	67,834
Apr 17, 2020	Landry Robert E EVP Finance CFO Trans History: 465	EVP Finance CFO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	9,250	$555.82	27,623
Apr 17, 2020	LAROSA JOSEPH J EVP General Counsel and Secret Trans History: 181	EVP General Counsel and Secret	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	3,602	$555.82	17,458
Apr 17, 2020	LAROSA JOSEPH J EVP General Counsel and Secret Trans History: 181	EVP General Counsel and Secret	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	2,720	$555.82	19,738

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media